# Mechanisms of Progranulin Deficiency in Neuroinflammation and Neurodegeneration

> **NIH VA I01** · VETERANS AFFAIRS MED CTR SAN FRANCISCO · 2020 · —

## Abstract

Microglia are resident macrophages in brain and spinal cord that function at the frontline of innate immunity
to respond and repair injuries and diseases. Despite the increasing attention to microglia, however, there are
many critical barriers in our knowledge regarding the molecular mechanisms that activate microglia and the
exact roles of microglial activation in neurodegenerative diseases. This new BLR&D Merit proposal focuses on
the role of frontotemporal lobar dementia (FTLD) gene Progranulin (Grn [gene], PGRN [protein]) in microglial
activation and neurodegeneration in mouse models of PGRN deficiency and in FTLD patients with Grn
mutations. Progranulin is a haploinsufficient gene frequently mutated in FTLD patients. Using global and
microglia-specific Progranulin knockout (Grn-/-) mice, we have recently shown that loss of PGRN promotes
microglial activation and neuronal degeneration in toxin-induced injury conditions. In our current work, we show
that PGRN deficiency leads to an age-dependent increase in microgliosis. In addition, large scale microarray
analyses in control and Grn-/- aging cohorts show progressive up-regulation of lysosomal and innate immune
response genes, including many key components in the classical complement activation pathway.
Interestingly, the persistent neuroinflammation in PGRN mutants most prominently affects the ventral posterior
medial (VPM) and ventral posterior lateral (VPL) nuclei of thalamus, which show features of
neurodegeneration, including severe synaptic loss and progressive loss of neuronal cell body, Consistent with
the critical role of these thalamic nuclei in connection with the barrel cortex and in habitual learning, aging Grn-/-
mutants exhibit obssessive compulsive behavioral deficits (OCD). These results raise the hypothesis that
PGRN deficiency leads to abnormal activation of microglia and facilitates neurodegeneration in a neural circuit
critical for sensorimotor functions. Our overall objective is to elucidate the mechanisms by which PGRN
deficiency lead to progressive microglial activation, pro-inflammatory gene expression, and contributions to
neurodegeneration in a neural circuit that is critical for sensoimotor integration and highly relevant to human
disease. We propose three specific aims to achieve this goal. In Aim 1, we will test the hypothesis that PGRN
deficiency in microglia cell autonomously activates pro-inflammatory molecular signatures and functional
characteristics. Aim 2 will generate inducible microglia-specific Grn (CX3CR1-CreER;Grnfl/fl) to test the
hypothesis that PGRN deficient microglia cell autonomously promote circuit-specific neurodegeneration. In Aim
3, we will use pharmacological and genetic approaches to inhibit complement activation, and to test the
hypothesis that aberrant complement activation contributes to the synaptic degeneration in the thalamocortical
ciruits in Grn-/- mutants. Our results will provide clear mechanistic insights on the role of PGRN in m...

## Key facts

- **NIH application ID:** 9814680
- **Project number:** 5I01BX002978-04
- **Recipient organization:** VETERANS AFFAIRS MED CTR SAN FRANCISCO
- **Principal Investigator:** Eric J Huang
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2020
- **Award amount:** —
- **Award type:** 5
- **Project period:** 2016-10-01 → 2020-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9814680

## Citation

> US National Institutes of Health, RePORTER application 9814680, Mechanisms of Progranulin Deficiency in Neuroinflammation and Neurodegeneration (5I01BX002978-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9814680. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
